Robert J. Lefkowitz - 21 May 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Robert J. Lefkowitz
Issuer symbol
LXRX
Transactions as of
21 May 2022
Net transactions value
$0
Form type
4
Filing time
23 May 2022, 16:14:45 UTC
Previous filing
02 May 2022
Next filing
28 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +14,402 $0.000000 14,402 21 May 2022 Common Stock 14,402 $1.77 Direct F1
transaction LXRX Restricted Stock Units Award $0 +9,302 $0.000000 9,302 21 May 2022 Common Stock 9,302 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
F2 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.